Blocking structural changes may restore the effectiveness of the cancer drug venetoclax, according to Rutgers Health ...

Watch as Gabe Fholer rings the bell to celebrate being cancer-free. Doctors say a breakthrough drug helped make it happen.

An international study conducted by the Alliance for Clinical Trials in Oncology and the Acute Myeloid Leukemia Cooperative Group reveals that age-based classifications in the treatment of acute ...

Patients in the ATRA-CHT arm received 45 mg/m 2 ATRA twice daily and 12 mg/m 2 idarubicin once daily on days 1, 3, 5, and 7, followed by three cycles of chemotherapy-based consolidation and 2 years of ...

Scientists at the University of Duisburg-Essen are researching new therapies for aggressive forms of childhood leukemia.